Back
Arvinas Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
60
ARVN
Arvinas
Last Price:
27.07
Seasonality Move:
93.82%
Sell
40
ALNY
Alnylam Pharmaceuticals
Last Price:
296.71
Seasonality Move:
11.91%
Buy
60
Arvinas (ARVN)
is a Buy
Is Arvinas a Buy, Sell or Hold?
- The current Arvinas [ARVN] share price is $27.80. The Score for ARVN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- ARVN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $300.55. The Score for ALNY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARVN Stock Price Chart
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $300.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARVN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 65.76 | Buy |
| Chaikin Money Flow: | 42457 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.35 - 25.91) | Buy |
| Bollinger Bands (100): | (24.03 - 28.89) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.76 | Buy |
| Relative Strength Index (14 RSI): | 75.52 | Buy |
| Chaikin Money Flow: | 1043301 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (266.78 - 282.26) | Buy |
| Bollinger Bands (100): | (196.41 - 285.77) | Buy |
ARVN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.82 | Buy |
| 20-day SMA: | 25.16 | Buy |
| 50-day SMA: | 25.15 | Buy |
| 200-day SMA: | 33.25 | Sell |
| 8-day EMA: | 26 | Buy |
| 20-day EMA: | 25.47 | Buy |
| 50-day EMA: | 25.71 | Buy |
| 200-day EMA: | 29.26 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 280.35 | Buy |
| 20-day SMA: | 275.91 | Buy |
| 50-day SMA: | 270.69 | Buy |
| 200-day SMA: | 200.56 | Buy |
| 8-day EMA: | 283.96 | Buy |
| 20-day EMA: | 277.03 | Buy |
| 50-day EMA: | 266.03 | Buy |
| 200-day EMA: | 219.81 | Buy |
Arvinas Earnings Growth & ARVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.66 per share, and a decrease next year of $1.40 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.32 per share, and an increase next year of $0.76 per share.
Arvinas Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||